Related Experiment Video
Updated: Feb 13, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan
Yoshio Takesue1, Shinya Kusachi2, Hiroshige Mikamo3
1The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Disease (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Prevention and Control, Hyogo College of Medicine, Hyogo, Japan.
Abstract:
The principle of empirical therapy for patients with intra-abdominal infections (IAI) should include antibiotics with activity against Enterobacteriaceae and Bacteroides fragilis group species. Coverage of Pseudomonas aeruginosa, Enterobacter cloacae, and Enterococcus faecalis is also recommended for hospital-associated IAI. A nationwide survey was conducted to investigate the antimicrobial susceptibility of pathogens isolated from postoperative IAI. All 504 isolates were collected at 26 institutions and referred to a central laboratory for susceptibility testing. Lower susceptibility rates to ciprofloxacin and cefepime were demonstrated in Escherichia coli. Among E. coli, 24.1% of strains produced extended-spectrum β-lactamase (ESBL). Carbapenems, piperacillin/tazobactam, cephamycins/oxacephem, aminoglycosides, and tigecycline had high activity against E. coli, including ESBL-producing isolates. Among E. cloacae, low susceptibility rates to ceftazidime were demonstrated, whereas cefepime retained its activity. P. aeruginosa revealed high susceptibility rates to all antimicrobials tested except for imipenem. Among B. fragilis group species, low levels of susceptibility were observed for cefoxitin, moxifloxacin, and clindamycin, and high susceptibility rates were observed for piperacillin/tazobactam, meropenem, and metronidazole. Ampicillin, piperacillin, and glycopeptides had good activity against E. faecalis. Imipenem had the highest activity against E. faecalis among carbapenems. In conclusion, we suggested the empirical use of antimicrobials with the specific intent of covering the main organisms isolated from postoperative IAI. Piperacillin/tazobactam, meropenem, or doripenem, are appropriate in critically ill patients. Combination therapy of cefepime (aztreonam in patients with β-lactam allergy) plus metronidazole plus glycopeptides, imipenem/cilastatin or cephamycins/oxacephem plus ciprofloxacin plus metronidazole are potential therapeutic options.
Insights
Empirical antibiotic therapy for intra-abdominal infections (IAI) requires coverage of key pathogens. This study assessed antimicrobial susceptibility, guiding optimal treatment choices for postoperative IAI patients.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Intra-abdominal infections (IAI) necessitate empirical antibiotic therapy targeting common pathogens like Enterobacteriaceae and Bacteroides fragilis.
- Hospital-associated IAI require additional coverage for Pseudomonas aeruginosa, Enterobacter cloacae, and Enterococcus faecalis.
Purpose of the Study:
- To investigate the antimicrobial susceptibility patterns of pathogens isolated from postoperative intra-abdominal infections.
- To inform empirical antibiotic therapy recommendations for IAI based on current pathogen resistance profiles.
Main Methods:
- A nationwide survey collected 504 isolates from postoperative IAI across 26 institutions.
- Isolates were tested for antimicrobial susceptibility at a central laboratory.
Main Results:
- Escherichia coli showed reduced susceptibility to ciprofloxacin and cefepime, with 24.1% producing extended-spectrum β-lactamase (ESBL). Carbapenems, piperacillin/tazobactam, and tigecycline demonstrated high activity against E. coli, including ESBL producers.
- Enterobacter cloacae had low susceptibility to ceftazidime but retained susceptibility to cefepime. Pseudomonas aeruginosa exhibited high susceptibility to most agents except imipenem.
- Bacteroides fragilis group species showed low susceptibility to cefoxitin, moxifloxacin, and clindamycin, but high susceptibility to piperacillin/tazobactam, meropenem, and metronidazole. Enterococcus faecalis was susceptible to ampicillin, piperacillin, glycopeptides, and imipenem.
Conclusions:
- Antimicrobial selection for empirical IAI therapy should target prevalent organisms, considering resistance patterns.
- Piperacillin/tazobactam, meropenem, or doripenem are suitable for critically ill patients.
- Combination therapies involving cefepime or cephamycins/oxacephem with other agents offer potential treatment options, with aztreonam as an alternative for beta-lactam allergic patients.
More Related Videos
12:39Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
Published on: June 24, 2011
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
Related Concept Videos
Common Ion Effect
Antimicrobial Effectiveness
Abdominal Aorta
The celiac trunk, a singular artery, divides into the left gastric artery, which...
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Susceptibility, Permittivity and Dielectric Constant